young-professional-team-discussing-business-plan-i-2022-02-02-21-53-56-utc-scaled-e1657877

BioSET

business-people-shake-hands-in-the-office-e1655897424318.jpg

More About Us

We Like to Meet Entrepreneurs

While we invest at Series A (generally, when a company is over $2M in revenue), we like to meet founders before they’re raising their Series A – to build a relationship, learn more about the company, and allow them to get to know us. Please do reach out.

ABOUT US

New Markets Team

Mark Grovic

Co-Founder and General Partner

Recent Posts

Dec 8, 2008

3

min read

BioSET

BioSET Announces Initiation of Clinical Trials for AMPLEX Osteo-Promotive Bone Graft System for Spine Fusion

Pilot Studies Initiated in both the U.S. and Canada, and First Patient Treated BioSurface Engineering Technologies, Inc., a privately...

Follow Us On

Status

Realized

Location

Visit

BioSET® is leading an orthobiologic revolution…a step beyond growth factors. By pairing biomimetic growth factors with biomaterial scaffolds, BioSET is redefining surgical grafting and tissue regeneration.

These combination products represent the next step in tissue regeneration technology, offering surgeons and their patients new and powerful tools for repairing damaged or diseased tissue in musculoskeletal surgery.